Dysregulation of lipid mediators in clinically stable bronchiectasis

P. Bedi (Edinburgh, United Kingdom), D. Davidson (Edinburgh, United Kingdom), B. Mchugh (Edinburgh, United Kingdom), A. Rossi (Edinburgh, United Kingdom), A. Hill (Edinburgh, United Kingdom)

Source: International Congress 2018 – Mechanisms of respiratory infection
Session: Mechanisms of respiratory infection
Session type: Thematic Poster
Number: 2646

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Bedi (Edinburgh, United Kingdom), D. Davidson (Edinburgh, United Kingdom), B. Mchugh (Edinburgh, United Kingdom), A. Rossi (Edinburgh, United Kingdom), A. Hill (Edinburgh, United Kingdom). Dysregulation of lipid mediators in clinically stable bronchiectasis. 2646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Microparticles from OSA patients induce hyper-reactivity through up-regulation of pro-inflammatory proteins
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005

Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010


Endogenous lipid mediators in the resolution of airway inflammation
Source: Eur Respir J 2007; 30: 980-992
Year: 2007



Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B.
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

FIZZ1: a new pathway in silica-induced inflammatory mediators and pulmonary fibrosis
Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Year: 2018

Involvement of GPx4-regulated lipid peroxidation in IPF pathogenesis.
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018



Extracellular vesicles are key intercellular mediators in the development of immune dysfunction to allergens in the airway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis
Source: Eur Respir Mon 2011; 52: 11-21
Year: 2011


Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007

Altered iron metabolism and elevated cellular senescence in COPD small airway epithelial cells
Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease
Year: 2020




Systemic inflammation and colonization in patients with clinically stable bronchiectasis
Source: Eur Respir J 2007; 30: Suppl. 51, 528s
Year: 2007

Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 10s
Year: 2004